Fulgent Genetics, Inc. (FLGT)
Healthcare • Diagnostics & Research
StockNasdaqGMUnited StatesUS3596641098
24.36 USD
-1.97% today Updated 13 Nov 2026 16:26
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by Fulgent Genetics, Inc., and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 13 Nov 2026 16:26. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Next results
26 Feb 2027
in 105 days · 16:00 · estimate -0.68
Last results
-0.09 vs -0.65 estimated
05 Nov 2026 · Beat +86.2%
Beat the estimate
10 of 12
2 missed · 0 in line
Average surprise
+147.2%
reported against the estimate, last 12 quarters
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 26 Feb 2027 16:00 | -0.68 | — | — | Upcoming |
| 05 Nov 2026 16:00 | -0.65 | -0.09 | +86.2% | Beat |
| 30 Jul 2026 16:00 | -0.44 | -0.58 | -32.2% | Miss |
| 01 May 2026 07:00 | -0.35 | -0.36 | -3.4% | Miss |
| 27 Feb 2026 07:00 | 0.03 | 0.16 | +436.4% | Beat |
| 07 Nov 2025 07:00 | -0.22 | 0.14 | +162.5% | Beat |
| 01 Aug 2025 07:00 | -0.18 | 0.07 | +137.9% | Beat |
| 02 May 2025 07:00 | -0.18 | 0.04 | +122.3% | Beat |
| 28 Feb 2025 07:00 | -0.37 | 0.04 | +110.8% | Beat |
| 08 Nov 2024 07:00 | -0.15 | 0.31 | +301.5% | Beat |
| 02 Aug 2024 07:00 | -0.30 | 0.15 | +150.2% | Beat |
| 03 May 2024 07:00 | -0.32 | -0.01 | +96.9% | Beat |
| 28 Feb 2024 07:00 | -0.29 | 0.28 | +197.9% | Beat |
| 03 Nov 2023 07:00 | -0.32 | -0.39 | -21.9% | Miss |
| 04 Aug 2023 07:00 | -0.33 | -0.08 | +75.5% | Beat |
| 05 May 2023 07:00 | -0.43 | -0.22 | +48.4% | Beat |
| 28 Feb 2023 16:00 | -0.56 | -0.48 | +14.3% | Beat |
| 07 Nov 2022 16:00 | 0.06 | 0.06 | +9.1% | Beat |
| 04 Aug 2022 16:00 | 0.73 | 0.78 | +6.9% | Beat |
| 03 May 2022 16:00 | 3.86 | 5.08 | +31.6% | Beat |
| 23 Feb 2022 16:00 | 2.67 | 3.48 | +30.6% | Beat |
| 09 Nov 2021 17:00 | 3.25 | 3.93 | +20.9% | Beat |
| 09 Aug 2021 16:00 | 2.67 | 2.59 | -3.0% | Miss |
| 06 May 2021 16:00 | 5.70 | 6.52 | +14.4% | Beat |
| 04 Mar 2021 16:00 | 4.05 | 6.20 | +53.0% | Beat |
| 09 Nov 2020 16:00 | 0.55 | 2.08 | +278.2% | Beat |
| 05 Aug 2020 06:00 | 0.01 | 0.17 | +1,600.0% | Beat |
| 04 May 2020 16:00 | 0.02 | -0.03 | -242.9% | Miss |
| 10 Mar 2020 16:00 | 0.02 | 0.04 | +105.1% | Beat |
| 04 Nov 2019 16:00 | 0.03 | 0.14 | +366.7% | Beat |
| 05 Aug 2019 16:00 | — | 0.06 | +3,100.0% | Beat |
| 07 May 2019 16:00 | -0.02 | -0.06 | -179.1% | Miss |
| 28 Feb 2019 16:00 | -0.01 | -0.01 | +33.3% | Beat |
| 06 Nov 2018 16:00 | -0.02 | — | +100.0% | — |
| 06 Aug 2018 16:00 | -0.03 | -0.01 | +66.7% | Beat |
| 07 May 2018 16:00 | -0.04 | -0.06 | -71.4% | Miss |
| 28 Feb 2018 16:00 | -0.02 | -0.06 | -267.4% | Miss |
| 06 Nov 2017 16:00 | 0.02 | -0.02 | -183.3% | Miss |
| 07 Aug 2017 16:00 | 0.02 | 0.02 | +25.0% | Beat |
| 08 May 2017 16:00 | 0.06 | 0.03 | -45.5% | Miss |
| 27 Feb 2017 16:00 | 0.07 | 0.06 | -12.7% | Miss |
| 14 Nov 2016 16:00 | 0.09 | 0.11 | +16.4% | Beat |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 322.7M | +13.8% | -60.5M | -18.8% | -1.97 | -39.7% | -124.2M |
| 2024 | 283.5M | -2.0% | -42.7M | -15.1% | -1.41 | +75.0% | -19.3M |
| 2023 | 289.2M | -53.3% | -167.8M | -58.0% | -5.63 | -221.6% | 4.8M |
| 2022 | 619M | — | 143.4M | 23.2% | 4.63 | — | 234.7M |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| 09 Nov 2026 – 13 Nov 2026 In progress | 23.86 | 27.41 | 23.33 | 24.36 | +2.61% | 2,423,356 | |
| 02 Nov 2026 – 06 Nov 2026 | 20.82 | 23.85 | 18.44 | 23.74 | +15.13% | 2,473,500 | |
| 26 Oct 2026 – 30 Oct 2026 | 20.14 | 21.77 | 20.08 | 20.62 | +2.59% | 1,355,900 | |
| 19 Oct 2026 – 23 Oct 2026 | 19.89 | 20.67 | 19.30 | 20.10 | +1.46% | 1,086,500 | |
| 12 Oct 2026 – 16 Oct 2026 | 21.74 | 21.80 | 19.73 | 19.81 | -8.88% | 1,364,500 | |
| 05 Oct 2026 – 09 Oct 2026 | 21.37 | 22.78 | 19.82 | 21.74 | +1.21% | 1,656,700 | |
| 28 Sep 2026 – 02 Oct 2026 | 21.99 | 22.59 | 21.07 | 21.48 | -3.24% | 1,392,700 | |
| 21 Sep 2026 – 25 Sep 2026 | 21.93 | 22.25 | 21.01 | 22.20 | +2.35% | 1,408,000 | |
| 14 Sep 2026 – 18 Sep 2026 | 20.46 | 21.88 | 20.10 | 21.69 | +6.06% | 2,125,700 | |
| 08 Sep 2026 – 11 Sep 2026 | 19.55 | 20.52 | 19.44 | 20.45 | +3.65% | 1,462,700 | |
| 252 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- Fulgent Genetics, Inc. 2026 Q3 - Results - Earnings Call Presentation (opens in a new tab) SeekingAlpha · 10 Nov 2026 18:24
- Piper Sandler Maintains Neutral on Fulgent Genetics, Raises Price Target to $25 (opens in a new tab) Benzinga · 10 Nov 2026 08:54
- Global Cardiovascular Genetic Testing Market Report 2026 | Capitalize on 11% CAGR and AI Genomics with Labcorp, Quest Diagnostics, Illumina, and Fulgent Genetics (opens in a new tab) 09 Nov 2026 14:08
- Fulgent Genetics (FLGT) Q3 2026 Earnings Call Transcript (opens in a new tab) Motley Fool · 06 Nov 2026 17:33
- Fulgent Genetics, Inc. Q3 2026 Earnings Call Summary (opens in a new tab) Moby · 06 Nov 2026 13:30
- Fulgent Genetics, Inc. (FLGT) Q3 2026 Earnings Call Transcript (opens in a new tab) SeekingAlpha · 06 Nov 2026 12:44
- Fulgent Genetics Inc (FLGT) Q3 2026 Earnings Call Highlights: Revenue Climbs 8% as Anatomic ... (opens in a new tab) GuruFocus.com · 06 Nov 2026 05:26
- What Fulgent Genetics (FLGT) Said on Its Q3 Earnings Call (opens in a new tab) MarketBeat · 06 Nov 2026 02:14
- Fulgent Genetics, Inc. (FLGT) Reports Q3 Loss, Beats Revenue Estimates (opens in a new tab) Zacks · 06 Nov 2026 00:00
- Fulgent Genetics (NASDAQ:FLGT) Q3 2026 Beat Faces Cautious Margin and Guidance Concerns (opens in a new tab) ChartMill · 05 Nov 2026 23:43
- Fulgent Reports Third Quarter 2026 Financial Results (opens in a new tab) 05 Nov 2026 21:05
- Fulgent Genetics Q3 2026 Earnings Call Transcript (opens in a new tab) Benzinga · 05 Nov 2026 18:15
- Fulgent Genetics Raises FY2026 Adj EPS Guidance from $(2.35)-$(2.22) to $(1.75)-$(1.65) vs $(2.27) Est; Affirms FY2026 Sales Guidance of $330.000M-$340.000M vs $331.700M Est (opens in a new tab) Benzinga · 05 Nov 2026 17:17
- Fulgent Genetics Q3 Adj. EPS $(0.09) Beats $(0.65) Estimate, Sales $90.412M Beat $86.300M Estimate (opens in a new tab) Benzinga · 05 Nov 2026 17:10
- PRPO vs. FLGT: Which Cancer Diagnostics Stock Has More Upside Now? (opens in a new tab) Zacks · 22 Sep 2026 18:16
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 24.85 USD
- Market cap
- 694.3M
- Exchange
- NasdaqGM
- Country
- United States
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Currency
- USD
Dividends
No dividends on record.
Why this score
Similar shares
Follow FLGT and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.